A popular anxiety drug is being recalled over a ‘life-threatening’ label mistake. In a recall alert for some lots of Clonazepam Orally Disintegrating Tablets the FDA states the medication is mislabeled with the incorrect strength on the carton and as a result,

What Happened? Pharmaceutical company Endo Inc. issued the recall after discovering that cartons of the anti-anxiety drug were mislabeled with incorrect dosage strengths and National Drug Codes (NDCs).

Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the incorrect strength have been added to a voluntary recall, according to the U.S. Food and Drug Administration.

Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life-threatening consequences.

Clonazepam, an anxiety drug, has been recalled because of a labeling error that could result in harmful consequences.

Drug manufacturer Endo announced on Friday that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, a popular anxiety drug,

Clonazepam, an anxiety drug, is being voluntarily recalled for the potential to cause a “life-threatening” event.

The company, Endo, recalled 16 product lots of clonazepam, a drug best known by the brand name Klonopin. The company said it had not received any reports of adverse events related to the recall. Clonazepam is among a class of psychiatric drugs called benzodiazepines,

The US Food and Drug Administration said taking wrong dose of Clonazepam could result in ‘significant sedation, confusion, dizziness, diminished reflexes, ataxia, and hypotonia’